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Reprogramming of nuclei allows the dedifferentiation
of differentiated cells. Somatic cells can undergo epi-
genetic modifications and reprogramming through
their fusion with embryonic stem cells (ESCs) or after
overexpression of a specific blend of ESC transcrip-
tion factor-encoding genes.We show here that cyclic
activation of Wnt/b-catenin signaling in ESCs with
Wnt3a or the glycogen synthase kinase-3 (GSK-3)
inhibitor 6-bromoindirubin-30-oxime (BIO) strikingly
enhances the ability of ESCs to reprogram somatic
cells after fusion. In addition, we show that reprog-
ramming is triggered by a dose-dependent accumu-
lation of active b-catenin. Reprogrammed clones
express ESC-specific genes, lose somatic differenti-
ation markers, become demethylated on Oct4 and
Nanog CpG islands, and can differentiate into cardi-
omyocytes in vitro and generate teratomas in vivo.
Our data thus demonstrate that in ESCs, periodic
b-catenin accumulation via the Wnt/b-catenin
pathway provides a specific threshold that leads to
the reprogramming of somatic cells after fusion.
INTRODUCTION
TheWnt/b-catenin signaling pathway regulates a variety of cellu-
lar processes during the development of vertebrates and inverte-
brates, including cell proliferation and differentiation, cell fate,
and organogenesis (Karner et al., 2006; Reya andClevers, 2005).
In addition, the Wnt/b-catenin pathway controls tissue homeo-
stasis and regeneration in response to damage in zebrafish,
Xenopus, planarians, and even adult mammals (Gurley et al.,
2008; Ito et al., 2007; Osakada et al., 2007; Petersen and Red-
dien, 2008; Stoick-Cooper et al., 2007; Yokoyama et al., 2007).
b-catenin links cadherins to the cytoskeleton in cell-cell adhe-
sion and acts as the intracellular signaling molecule of the Wnt
pathway. The binding of Wnt ligands to Frizzled and LRP5/6
receptors results in inactivation of a multiprotein destruction
complex, which is composed of glycogen synthase kinase-3
(GSK-3), Axin, and adenomatous polyposis coli (APC). This inac-
tivation leads to a decrease in b-catenin phosphorylation, which
then allows b-catenin to escape ubiquitin-proteasome-mediated
degradation (Willert and Jones, 2006). As a consequence,Cnondegraded b-catenin accumulates in the cytoplasm and
translocates into the nucleus, leading to transcriptional activa-
tion of a plethora of target genes that control a variety of cellular
and tissue processes (Hoppler and Kavanagh, 2007). In the
absence of Wnt activation, b-catenin is phosphorylated by the
destruction complex and degraded by the ubiquitin-proteasome
system. Activation of Wnt/b-catenin signaling induces the
expression ofmultiple antagonists that act in a coordinatedman-
ner to shut down the pathway at many levels simultaneously.
Extracellularly, the Wif-1 and Dkk proteins inhibit Wnt signaling
by interacting with the Wnt protein and LRP5/6 receptors,
respectively (Kawano and Kypta, 2003). Intracellularly, both
Nkd-1 and Axin2 enhance b-catenin degradation through an
increase in the formation of the destruction complex (Behrens,
2005; Wharton et al., 2001).
The Wnt proteins form a large family of isoforms (fromWnt1 to
Wnt10b, Wnt11, and Wnt16) (Kikuchi et al., 2007). Among these,
Wnt3a has been shown to enhance self-renewal and to maintain
totipotency of embryonic stem cells (ESCs) and hematopoietic
stem cells (HSCs) (Anton et al., 2007; Reya et al., 2003) through
the accumulation of b-catenin in the cell nucleus. Likewise, both
inactivation of theGSK-3a andGSK-3b homologs andmutations
in APC lead to b-catenin stabilization and severely compromise
the ability of ESCs to differentiate and to maintain their stemness
(Doble et al., 2007; Kielman et al., 2002; Sato et al., 2004).
Reprogramming can allow dedifferentiation of differentiated
cells to pluripotency and can take place via different mecha-
nisms. Somatic nuclear transfer has allowed the cloning of
different animals through the reprogramming of a differentiated
nucleus (Vajta, 2007). Recent findings have shown that overex-
pression of four specific ESC transcription factors encoding
genes in mouse and human somatic cells can induce them to
become pluripotent (Aoi et al., 2008; Brambrink et al., 2008;
Hanna et al., 2008; Kim et al., 2008; Lowry et al., 2008; Maherali
et al., 2007; Park et al., 2008; Takahashi et al., 2007; Takahashi
and Yamanaka, 2006; Yu et al., 2007). Somatic mouse and
human cells can also be reprogrammed by fusion with ESCs
and Nanog, a factor that maintains ESCs in their undifferentiated
state and augments the pluripotency of the hybrids (Cowan et al.,
2005; Silva et al., 2006; Tada et al., 1997, 2001). In ESC-thymo-
cyte hybrids, reactivation of the inactive X chromosome, erasure
of DNA methylation associated with imprinted genes, and
reactivation of the Oct4-GFP transgene have all been seen.
Moreover, when these hybrid cells were introduced into host
diploid blastocysts, they contributed to the three germ layers
of the chimeric embryos (Tada et al., 1997, 2001). Similarell Stem Cell 3, 493–507, November 6, 2008 ª2008 Elsevier Inc. 493
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with human ESCs. The tetraploid hybrids obtained showed the
phenotype and growth rate of the human ESCs. The somatic
genome was reprogrammed, as demonstrated by human-ESC-
like genomewide transcriptional analysis (Cowan et al., 2005).
Since Wnt/b-catenin signaling controls ES self-renewal and
the maintenance of stemness (Sato et al., 2004) and regulates
the expression of ESC genes (Cole et al., 2008), we hypothesized
that the Wnt/b-catenin signaling pathway can also control the
reprogramming of somatic cells to pluripotency. Here we show
that periodic b-catenin accumulation enhances reprogramming
of somatic cells via cell fusion. By culturing ESCs transiently
with Wnt3a or with the GSK-3 inhibitor 6-bromoindirubin-30-
oxime (BIO), we show that cyclic Wnt/b-catenin signaling
enables these treated ESCs to reprogram a variety of different
somatic cells after fusion. The isolated reprogrammed clones
are pluripotent, since they are able to differentiate in vitro and
in vivo.
RESULTS
Activation of the Wnt/b-Catenin Signaling Pathway
Enhances Reprogramming of Somatic Cells after Fusion
We used polyethyleneglycol (PEG) to generate fusion hybrids
between ESCs constitutively expressing the NeoR gene, and
mouse neural stem (NS)-Oct4-puro/GFP cells (Silva et al., 2006)
expressing the PuroR gene and green fluorescent protein (GFP)
under the control of the Oct4 (Pou5f1) regulatory element that is
only active in pluripotent cells (Yeom et al., 1996). Immediately
after fusion, the cells were cultured in gelatin (without feeders
that express different Wnt isoforms [Dravid et al., 2005; Wiese
et al., 2006]) for 12, 24, 48, and 72 hr (Figure 1A) in the presence
of an optimized concentration ofWnt3a (100 ng/ml; see Figure S1
available online). Hybrids were selected in ESC medium supple-
mented with puromycin; under these culture conditions, only
reprogrammed clones can grow. ESC medium induces differen-
tiation and growth arrest of NS cells and thus of nonreprog-
rammed hybrids, too. Furthermore, puromycin provides
additional selection for the reprogrammed clones (Figure S2).
The resistant colonies were stained for the expression of alka-
line phosphatase (AP), an ESC marker, and counted (Figure 1A).
These cells had been reprogrammed, as they retained a rounded
ESC-like phenotype and expressed AP and Oct4-puro/GFP
(Figures 1A and 1B). We selected up to 20-fold more reprog-
rammed clones with respect to the control after 24 hr of Wnt3a
culturing. The number of reprogrammed clones decreased after
72 hr of treatment, indicating that prolonged Wnt3a culturing
might diminish the reprogramming efficiency. These data clearly
showed that time-dependent Wnt3a treatment greatly enhances
the ability of ESCs to reprogram NS cells.
In support of these data, a very high number of AP-positive
reprogrammed clones (between 30 and 300) showing an ESC-
like phenotype were obtained when mouse embryonic fibro-
blasts (MEFs) expressing different Wnt isoforms (Dravid et al.,
2005; Wiese et al., 2006) were fused with ESCs. This number
increased up to 5-fold when these hybrids were cultured in the
presence of Wnt3a for 48 hr (Figure 1C). Finally, to confirm that
activation of the Wnt/b-catenin pathway enhances somatic cell
reprogramming, we inhibited this pathway with Dkk1, an LRP6494 Cell Stem Cell 3, 493–507, November 6, 2008 ª2008 Elsevier Inreceptor inhibitor (Logan and Nusse, 2004). The striking
decrease in the number of reprogrammed, AP-positive clones
(up to 6-fold; Figure 1C) demonstrates that the Wnt/b-catenin
signaling pathway stimulates the reprogramming of somatic
cells.
Transient Inhibition of GSK-3 in ESCs Enhances
Their Ability to Reprogram Different Somatic Cells
To confirm that cell reprogramming is augmented through the
activation of the canonical Wnt/b-catenin signaling pathway,
we decided to transiently inhibit GSK-3 by addition to the culture
medium of the selective GSK-3 inhibitor 6-bromoindirubin-30-
oxime (BIO) (Meijer et al., 2003). This inhibition of GSK-3 mimics
the activation of the pathway viaWnt3a, as it promotes the accu-
mulation of b-catenin in the cell nucleus (Meijer et al., 2003) and
maintains the pluripotency of stem cells (Sato et al., 2004). Ini-
tially, to exclude a direct role of BIO in enhancing clonogenicity
and/or viability of ESCs and hybrid clones, we plated scaled
numbers of ESCs or hybrids in BIO-containing medium. This
demonstrated that the clonogenicity and viability of both ES
and hybrids cultured in the absence and presence of BIO, re-
spectively, were equal (Figures S3A and S3B). In addition, since
theWnt/b-catenin signaling pathway is regulated by an inhibitory
feedback loop (Ueno et al., 2007), we tested different concentra-
tions of BIO to determine the concentration that mimics this
physiological regulation most closely: addition of 1 mM BIO led
to the relatively limited activation of the TOPflash reporter gene
(a vector harboring b-catenin binding sites fused to luciferase)
and resembled the level of activity upon Wnt3a stimulation
(Figure S4A). In addition, higher BIO concentrations were slightly
toxic to NS cells (data not shown). Thus, we used 1 mM BIO as
standard under the remaining experimental conditions.
We then analyzed the effects of BIO treatment over time.
PEG-fused ES-neo 3 NS-Oct4-puro cells were cultured for 12,
24, 48, and 72 hr with this optimized concentration of BIO (1 mM;
Figure 2A). After 24 hr of treatment, we obtained up to 70-fold
more reprogrammed clones (from 200 to 1500 total clones),
with respect to the control (Figure 2A). Reprogramming was de-
pendent on the time of BIO stimulation, with a decreased number
of reprogrammed clones after 72 hr of treatment. The selected
hybrids were reprogrammed, as they showed an ESC-like phe-
notype, were AP positive, and expressed GFP-puro (Figures
2A and 2B). However, to exclude a role of BIO as an enhancer
of cell fusion, we performed further control experiments. BIO
did not enhance PEG-mediated fusion of ESCs, as there was
only a slight increase in the number of clones after the fusion
of BIO-pretreated ES-neo cells with ES-hygro cells (Figure S5A).
In the fusion of ES 3 ESCs, we could only select for hybrids and
not for reprogrammed clones, and the number of clones
obtained was comparable. Furthermore, to better exclude the
possibility that BIO has a fusogenic activity on different cell
types, we PEG fused ES-neo 3 NS-Oct4-puro cells for 3 hr
and then replated the hybrids at a dilution such that the cells
were not in contact with each other. Thus, BIO was added to
the cell medium for 12, 24, 48, and 72 hr (Figure S5B). The
hybrids were formed before the addition of BIO, and they could
not increase further since the cells were not touching each other.
Nevertheless, however, reprogrammed clones were selected
with a pick at 24 hr of BIO treatment. (Figure S5B). This furtherc.
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b-Catenin Enhances Cell ReprogrammingFigure 1. Activation of the Wnt Pathway by Wnt3a Enhances Reprogramming Mediated by Cell Fusion
(A) Representative plates and quantification (as fold increases in the number of colonies) of hybrid colonies from PEG fusions of ES-neo cells with NS-Oct4-puro
cells treated with Wnt3a, as indicated. Colonies were stained for expression of AP and counted (mean ± SEM; n = 3).
(B) Fluorescence images of some reprogrammed hybrid colonies following 24 hr Wnt3a treatment (103 magnification).
(C) Quantification of hybrid colonies from PEG fusions of ES-neo cells and MEF-hygro cells untreated and treated with Dkk1 and Wnt3a, as indicated
(mean ± SEM; n = 3).Cell Stem Cell 3, 493–507, November 6, 2008 ª2008 Elsevier Inc. 495
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b-Catenin Enhances Cell ReprogrammingFigure 2. Activation of the Wnt/b-Catenin Pathway by BIO Enhances the Number of Reprogrammed Hybrid Colonies in Three Different
Cell-Type Fusions
(A) Quantification (as fold increases in the number of colonies) of hybrid colonies from PEG fusions of ES-neo cells with NS-Oct4-puro cells treated with BIO, as
indicated. (A and C) Representative plates and (A, C, and E) fold increases in the number of colonies of hybrids clones from the indicated fusions treated with BIO,
as indicated, stained for AP expression and counted. The fold change increases in the reprogrammed colonies are also shown in the graphs (mean ± SEM; n = 3).
(B, D, and F) Light microscopy images of some reprogrammed hybrid colonies following 24 hr BIO treatment (103 magnification).496 Cell Stem Cell 3, 493–507, November 6, 2008 ª2008 Elsevier Inc.
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fusion, of cells.
Inhibition of GSK-3 with BIO also strikingly increased the
numbers of reprogrammed colonies when MEFs and thymo-
cytes were fused with ESCs. PEG-fused hybrids of ES-neo 3
MEF-hygro and ES-hygro 3 thymocyte-neo cells were cultured
in BIO for 12, 24, 48, and 72 hr and double-drug selected. There
were up to 20-fold (between 200 and 1500 total clones) and
9-fold (between 20 and 100 total clones) increases, respectively,
in the numbers of reprogrammed selected clones, with respect
to their controls (fusions in the absence of BIO; Figures 2C
and 2E). Again, the reprogramming efficiency was lower with
increased treatment time with BIO. All of the selected clones
showed an ES-like phenotype and were AP positive (Figures
2C–2F).
These data demonstrate that transient inhibition of GSK-3
greatly enhances the ability of ESCs to reprogram somatic cells.
Furthermore, this reprogramming occurs with variable timing
across different cell types.
Cyclic Stabilization of b-Catenin in ESCs Enhances
Their Ability to Reprogram NS Cells
We then asked whether the activation of theWnt/b-catenin path-
way in ESCs would strengthen and enhance their reprogram-
ming ability. Thus, we investigated whether an enhancement of
reprogramming occurs when ESCs and/or NS cells are cultured
withWnt3a or BIO before their fusion. ESCswere thus cultured in
Wnt3a or BIO for 12, 24, 48, 72, and 96 hr and fused with
NS-Oct4-puro cells grown in the absence of BIO. Up to 15-fold
(about 600 total clones) or 80-fold (about 2000 total clones) in-
creases in the numbers of reprogrammed clones were seen
when ESCs were precultured for 24 and 96 hr with Wnt3a or
BIO, respectively (Figures 3A and 4A); the selected clones
showed an ESC-like phenotype, were AP positive, and ex-
pressed Oct4 (Figures 3A, 4A, and 4B). In contrast, there was
poor enhancement of NS reprogramming with the ESCs cultured
with Wnt3a or BIO for 12, 48, and 72 hr. To ensure that pretreat-
ment of ESCs with BIO before fusing them with NS-Oct4-puro
cells did not increase fusion, PEG-fused cells were cultured for
3 hr, an insufficient time for reprogramming to occur, and FACS
analysis was carried out. The same number of hybrid clones was
seen whether the ESCs were pretreated or not with BIO before
the fusion, thus excluding BIO-dependent, enhanced fusogenic
activity (Figure S6). We thus asked why there was a parabolic
wave of reprogramming through the periods of Wnt3a and BIO
treatment. This appeared to be due to b-catenin accumulation
in both Wnt3a- and BIO-treated cells at 24 and 96 hr (Figures
3B and 4C) and to its consequent localization in the cell nucleus
at these two times of treatment (Figures 3C and 4D). These data
show that reprogramming can be triggered only after the cyclic
accumulation of b-catenin. While 12 hr of Wnt3a or BIO treat-
ment was not sufficient to accumulate enough b-catenin to
trigger reprogramming, 24 hr (and 96 hr) of Wnt3a or BIO pre-
treatment of ESCs resulted in the accumulation of b-catenin; at
the same times, Axin2, Dkk4, and APC were also expressed,
leading to a negative feedback loop on the Wnt/b-catenin path-
way (Bazzi et al., 2007; Doble et al., 2007; Jho et al., 2002; Lustig
et al., 2002; Niida et al., 2004; Yan et al., 2001) that affected the
subsequent 48 and 72 hr time points (Figures 3B, 3D, 3E, 4C, 4E,Ceand 4F and data not shown). The wave of b-catenin accumula-
tion is similar in both Wnt3a- and BIO-treated ESCs. This might
be due to the relatively low concentration of BIO used here,
which might not inhibit GSK-3 activity fully, thus resembling the
feedback loop regulation in Wnt3a-treated cells. Indeed, with
1 mMBIO, the amount of phospho-b-catenin in ESCs was higher
with respect to the cells treated with increased BIO concentra-
tions, and moreover, the nuclear accumulation of the nonphos-
phorylated form was rather low. This leads to the conclusion
that GSK-3 was not fully inhibited by 1 mM BIO (Figures S4B
and S4C). To confirm that the increased expression of Axin2 was
preventing the reprogramming, we generated stable ES clones
overexpressing Axin2 (ES-Axin2) and fused them with NS-Oct4-
puro cells. No reprogrammed clones were selected after fusion
with five different ES-Axin2 clones (Figure S7). In conclusion,
activation of Wnt/b-catenin signaling is a key mechanism for
the reprogramming of somatic cells, and only when b-catenin
accumulates in ESCs to a certain threshold can these cells
reprogram NS cells after fusion.
Remarkably, Wnt3a- and BIO-treated ESCs expressed the
same levels of the pluripotent genes Nanog, Oct4, Rex1, and
Fgf4 at all of the treatment times, whereas expression of the
b-catenin-dependent genes Cdx1, Axin2, and Dkk4 cycled
according to the accumulation of the b-catenin protein itself
(Figures 3D, 3E, 4E, and 4F). Of note, although c-Myc, a known
b-catenin target gene (He et al., 1998), has previously been
shown to enhance reprogramming when overexpressed to-
gether with three other genes (Takahashi and Yamanaka,
2006), here it was constantly expressed under Wnt3a and BIO
treatments. These data suggest that pretreatment of ESCs
with Wnt3a or BIO results in the activation of the Wnt/b-catenin
signaling pathway and expression of specific b-catenin target
gene(s) that in turn stimulate the reprogramming of somatic cells.
This pathway is independent of Nanog, Oct4, Rex1, Fgf4, and
c-Myc; indeed, these genes were expressed at the same levels
throughout the different Wnt3a and BIO treatments.
The alternative of pretreatment of NS cells with BIO led to
b-catenin accumulation at 24 and 72 hr but provided poor
enhancement of reprogramming, with only a slight increase in
the number of ESC-like, AP-positive reprogrammed clones (Fig-
ure 4A and Figure S8). Thus, the Wnt/b-catenin signaling path-
way drives a remarkable enhancement of reprogramming of
somatic cells only when it is activated in ESCs.
Next, we wanted to better characterize the mechanism of
activation of reprogramming and to ensure that b-catenin is
a key factor in the reprogramming mechanism of somatic cells.
We asked whether ESCs expressing different levels of b-catenin
have different reprogramming abilities. For this, we generated
stable ES clones overexpressing different levels of the stabilized
b-catenin (ES-b-catenin) harboring a mutation in one of its
destruction-complex-dependent phosphorylation sites. We
selected five clones that activated expression of the TOPflash
reporter gene with different degrees of activity, with E1 and
F19 being the least active, A13 and A12 with intermediate
activity, and C2 being the most active and the most similar to
GSK-3/ ESCs, which accumulate a constant and high amount
of b-catenin (Doble et al., 2007) and greatly activate TOPflash
(Figure 5A). A very high number of reprogrammed clones (up to
a 55-fold increase) was generated after fusion of the E1 and ofll Stem Cell 3, 493–507, November 6, 2008 ª2008 Elsevier Inc. 497
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was generated upon fusion with the A13 and A12 clones (up to
an 18-fold increase), and almost no reprogrammed clones
were selected after fusion of the C2 clone and of GSK-3/ cells
(Figure 5B). Of note, the E1 clone activated the TOPflash reporter
gene to a similar extent to that seen for 1 mMBIO or Wnt3a 24 hr-
treated cells (Figure 5C), leading to the conclusion that these
cells express similar levels of active b-catenin and therefore
have comparable reprogramming capacities. These data clearly
demonstrate that reprogramming occurs only when the levels of
b-catenin are neither too low nor too high; the levels of b-catenin
need to be within an intermediate physiological level, which the
E1 and F19 clones and both Wnt3a- and 1 mM BIO-treated
ESCs have.
Isolated Clones Are Reprogrammed
and Can Differentiate In Vitro and In Vivo
To confirm pluripotency, and thus the ESC-like phenotype, 21
different reprogrammed clones were isolated from the fusion
of ESCs pretreated with BIO for 24 hr with NS-Oct4-puro cells.
The clones were all tetraploids (Figure 6A), were GFP positive,
and expressed Oct4, Nanog, and Rex1 after several passages
(Figure 6B). In contrast, the neural Blbp and Olig2 genes were
shut off (Figure 6C and Figure S9). Likewise, ES 3 thymocytes
and ES 3 MEF reprogrammed hybrids expressed Oct4 and
Nanog and lost expression of CD4 and CD8, and Col1a1-
and Col1a2-specific markers, respectively (Figure S10A). Fur-
thermore, bisulfite genomic sequence analysis revealed that
in the ES 3 NS reprogrammed clones, the CpG islands of the
Nanog and Oct4 promoters were highly demethylated and
were comparable to ESCs, suggesting that these two loci
had undergone massive epigenetic modifications; in contrast,
the same CpGs were highly methylated in parental NS cells
(Figure 6D). These data clearly show that the hybrids isolated
from the fusions with ESCs pretreated with BIO had been
reprogrammed.
Next, to determine the differentiation ability of the reprog-
rammed clones, we induced those of ES 3 NS, ES 3 thymo-
cytes, and ES3MEFs to spontaneous differentiation. Embryoid
bodies were formed: ball-shaped structures were clearly visible
after 3 days and underwent differentiation after 6 and 9 days
(Figure 6E and Figure S10B). Expression of Oct4 (pluripotent
stem cell), AFP (endoderm), Brachyury (mesoderm), Nkx2.5
(cardiac muscle), and GATA4 (cardiac muscle) were seen at 3,
5, 7, and 9 days of differentiation, with their expected timing
(Boheler et al., 2002), and as comparable to ESCs (Figure 6F
and Figure S10C). Furthermore, some of the clones started
beating spontaneously, demonstrating their differentiation into
cardiomyocytes (Figure S11).CeFinally, to test the differentiation ability of ES 3 NS hybrids
in vivo, we transplanted five different clones subcutaneously in
immunodeficient (SCID) mice. Three weeks after injection, tera-
tomas were seen (Figure S12). Histological examination showed
the presence of gut-like epithelial tissue (endoderm), striated
muscle and adipose tissue (mesoderm), neural tissue, epider-
mis, and cartilage (ectoderm) (Figure 6G).
These data clearly demonstrate the differentiation ability of the
reprogrammed clones, both in vitro and in vivo.
DISCUSSION
We have shown here that transient activation of the Wnt/b-cate-
nin signaling pathway leads to a cyclic accumulation of b-catenin
in ESCs that enables them to reprogram somatic cells after
fusion. When and only when a specific level of b-catenin is
stabilized and translocates into the nucleus are ESCs able to
reprogram differentiated cells; in contrast, when b-catenin is
degraded, reprogramming does not occur. The different levels
of b-catenin over time are likely to be due to the expression of
some of its inhibitory targets, such as Axin2 andDkk4, which sta-
bilize the destruction complex and inhibit Wnt receptors, respec-
tively. A negative feedback loop of the Wnt/b-catenin signaling
pathway has been shown in differentiating ESCs, which can
result in both positive and negative effects on cardiogenesis
(Ueno et al., 2007). Indeed, we have shown that overexpression
of Axin2 in ESCs impairs their reprogramming ability. The peri-
odic accumulation of active b-catenin or low amounts of a stabi-
lized b-catenin mutant are thus essential in the reprogramming
process; in contrast, stable and high levels of b-catenin affect
the ability of ESCs to reprogram somatic cells (Figure 7).
Why is the level and timing of b-catenin accumulation so im-
portant for reprogramming efficiency? A stable gain-of-function
form of b-catenin can lead to tumor formation (Katoh and Katoh,
2007). In addition,GSK-3/ ESCs that express stable b-catenin
levels cannot differentiate (Doble et al., 2007; Kielman et al.,
2002), and we have shown that these cells, as ES clones harbor-
ing high b-catenin activities, are not able to reprogram somatic
cells. On the other hand, a loss of function of b-catenin has
severe defects in mouse development at the gastrulation stage
(Haegel et al., 1995; Huelsken et al., 2000) and b-catenin/
ESCs do not express some stem cell markers (Anton et al.,
2007). Furthermore, we have shown here that basal levels of
active b-catenin in ESCs can activate reprogramming only very
poorly.
Thus, both loss of function and gain of function of b-catenin are
highly toxic for cells, with grave effects on their differentiation
ability and capacity to induce reprogramming. In contrast,
transient Wnt/b-catenin signaling activation is regulated by theFigure 3. CyclicWnt/b-Catenin Signaling Pathway Activation viaWnt3a Enables ESCs to ReprogramNSCells without Activation of StemCell
Genes
(A) Representative plates and quantification (as fold increases in the number of colonies) of hybrid colonies from PEG fusions betweenWnt3a-pretreated ES-Neo
cells and nontreated NS-Oct4-puro cells, as indicated. Colonies were stained for the expression of AP and counted (mean ± SEM; n = 3).
(B) Western blotting of protein extracts from ESCs from the Wnt3a-pretreatments in (A), as indicated.
(C) Immunofluorescence for the visualization of b-catenin localization in ESCs from the Wnt3a-pretreatments in (A), as indicated.
(D) Semiquantitative RT-PCR analysis of ESC-specific genes (Nanog,Oct4,Rex1, and Fgf4) and b-catenin targets (Axin2,Cdx1, and c-Myc) in total mRNApurified
from ESCs from the Wnt3a-pretreatments in (A), as indicated.
(E) Quantitative RT-PCR analysis of Axin2 and Nanog transcript levels in ESCs from the Wnt3a-pretreatments in (A), as indicated (mean ± SEM; n = 3).ll Stem Cell 3, 493–507, November 6, 2008 ª2008 Elsevier Inc. 499
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ing in waves of its accumulation up to a specific threshold and
the induction of reprogramming.
Once in the nucleus, b-catenin activates different target genes
(Katoh and Katoh, 2007). Here, we postulate that one or more
factors, the ‘‘reprogrammers’’ that are not constitutively ex-
pressed in ESCs, are transcribed upon b-catenin binding and
switch on a cascade of events that triggers the reprogramming
of the genome of the somatic nucleus. This is suggested also
by the finding that reprogramming occurs with variable timing
across various cell types, which leads to the prediction that
b-catenin initiates a complex program of events that can last
for different times in different cell types.
Reprogramming could be due to trans-acting factors that can
trigger transcription and/or suppression of somatic-nucleus-
specific genes, implying that these factors must be present
constantly to maintain the nondifferentiated phenotype. Alterna-
tively, the induction of a new heritable epigenetic modification of
the somatic nucleus could switch a program, resulting in mas-
sive chromatin modifications. Whatever the mechanism is, the
transcription of the reprogrammer(s) itself is probably finely
tuned by checkpoint controls that regulate its concentrations; in-
deed, high levels of stabilized b-catenin in GSK-3/ or C2 cells
that had skipped destruction complex inactivation abolished the
reprogramming ability of ESCs, leading us to envisage that there
are alternative checkpoint systems that control the concentra-
tions of the reprogrammer(s) that might come into action.
In human and mouse ESCs, the polycomb group (PcG) pro-
teins show transcriptional repression of the expression of devel-
opmental genes, which would otherwise promote differentiation
(Boyer et al., 2006b; Lee et al., 2006). The chromatin structure of
many of these PcG-regulated genes contains ‘‘bivalent domain’’
modifications that consist of both inhibitory histone H3 lysine 27
methylation and activating histone H3 lysine 4methylationmarks
(Bernstein et al., 2006). Furthermore, master regulators of pluri-
potency, like Oct4, Sox2, and Nanog, control genes that encode
transcription factors, chromatin-modifying enzymes, and signal-
transduction proteins that regulate ESC self-renewal (Boyer
et al., 2006a; Loh et al., 2006). During the reprogramming pro-
cess, one or more reprogrammers, as specific b-catenin targets,
might initiate the modifications of the chromatin state of the
somatic nucleus, finally resulting in the establishment of pluripo-
tent, ES-like genomic features, containing PcG-regulated
bivalent domain modifications and Oct4-, Sox2-, and Nanog-
regulated genes.
In culture, the generation of induced pluripotent stem cells
(iPS) demonstrates that pluripotency can be obtained by overex-Cepression of defined transcription factors, including stem cell
genes; however, this process is not likely to occur in vivo, since
factors like Nanog, Oct4, and Sox2 are not expressed in adult tis-
sues or in adult somatic stemcells andsince theyaredispensable
for adult stem cell function (Lengner et al., 2007). On the other
hand, overexpression of a blend of these transcription factors is
a potent recipe for the generation of novel stem cells in culture
that will hopefully be a powerful resource for medical
applications. Our data demonstrate that transient and periodic
activation of the Wnt/b-catenin signaling pathway without
overexpression of any of the known ESC genes can control
the reprogramming of somatic cells, mimicking a physiological
scenario that might occur in vivo. Remarkably, adult mouse
liver cells express high levels of b-catenin, and the efficiency of
selection of iPS-hepatocytes appears to be greater with respect
to iPS-fibroblasts, even if the number of retroviral integrations of
the reprogramming factors is lower in liver cells (Aoi et al., 2008).
These findings indicate that Wnt signaling can enhance the
generation of iPS cells. This was recently demonstrated
by Marson et al. (2008) while the present paper was in revision,
as they showed that iPS lines can be isolated with high efficiency
from MEFs cells transduced with lentiviruses encoding
Oct4, Sox2, and Klf4 and cultured in Wnt3a-CM (Wnt3a-condi-
tioned medium). Of note, and in agreement with our data,
Marson et al. (2008) showed that the Wnt-mediated mechanism
of reprogramming is independent of c-Myc. However, they
were not able to reproduce the effects of Wnt3a-CM on reprog-
ramming with GSK-3 inhibitors. This was potentially due to the
prolonged culture in medium containing the inhibitors that, as
we have shown here, have negative effects on reprogramming.
Isolated reprogrammed clones can differentiate in vivo and
in vitro. The process of achieving full reprogramming is slow,
as was seen in iPS cells that expressed detectable amounts of
GFP weeks after antibiotic selection (Jaenisch and Young,
2008). Interestingly, in the present study, the selected hybrids
were soon fully reprogrammed while they were drug selected,
since they expressed high levels of GFP and puromycin at the
same time.
One question arises finally: can the Wnt signaling-mediated
reprogramming of somatic cells occur upon spontaneous cell
fusion? PEG-independent fusion has been shown for different
cell types, but it is a very rare event (Ogle et al., 2005). This
is probably because the majority of hybrids formed are forced
to undergo differentiation under the culturing conditions used.
It will be of interest in the future to determine if reprogram-
ming of spontaneously fused cells can be enhanced by
the activation of the Wnt/b-catenin signaling pathway. ThisFigure 4. Periodic Accumulation of b-Catenin in ESCs via BIO Inhibition of GSK-3 Augments the Reprogramming of NS Cells without
Activation of Stem Cell Genes
(A) Representative plates and quantification of hybrid colonies from PEG fusions between BIO-pretreated ES-Neo cells and nontreated NS-Oct4-puro cells, as
indicated. Colonies were stained for the expression of AP and counted. The quantification also shows BIO-pretreated NS-Oct4-puro cells fused with nontreated
ES-Neo cells (gray bars) (mean ± SEM; n = 3).
(B) Light microscopy image of a reprogrammed hybrid colony isolated from fusions with 24 hr BIO-pretreated (24 hr) ES-neo cells and NS-Oct4-puro cells
(103 magnification).
(C) Western blotting of protein extracts from BIO-pretreated ESCs in (A), as indicated.
(D) Immunofluorescence for the visualization of b-catenin localization in ESCs from the BIO-pretreatments in (A), as indicated.
(E) Semiquantitative RT-PCR analysis of ES markers (Nanog, Oct4, Rex1, and Fgf4) and b-catenin targets (Axin2, Cdx1, and c-Myc) in total mRNA purified from
BIO-pretreated ESCs in (A), as indicated.
(F) Quantitative RT-PCR analysis of Axin2 and Nanog transcripts in BIO-pretreated ESCs (mean ± SEM; n = 3).ll Stem Cell 3, 493–507, November 6, 2008 ª2008 Elsevier Inc. 501
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(A) Luciferase reporter assay of ES-b-catenin clones nucleofected with the TOPflash reporter construct.
(B) Quantification (as fold increases in the number of colonies) of hybrid colonies from PEG fusions of ES-b-catenin clones (E1, F19, A13, A12, C2) with
NS-Oct4-puro cells, and from PEG fusion of wild-type ES or GSK-3/ cells with NS-Oct4-puro cells, as indicated (mean ± SEM; n = 3).
(C) Luciferase reporter (TOPflash) assay of ESCs untreated and treated for 24 hr with 1 mm BIO or 100 ng Wnt3a and of the E1 clone (mean ± SEM; n = 3).502 Cell Stem Cell 3, 493–507, November 6, 2008 ª2008 Elsevier Inc.
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NS-Oct4-puro cells isolated from HP165 mice and carrying the regulatory
sequences of the mouse Oct4 gene driving GFP and puromycin resistance
genes were a gift fromDr. A. Smith; they were cultured as previously described
(Conti et al., 2005). Thymocytes were isolated from 6- to 8-week-old mice.
Hygromycin-resistant MEFs were purchased at passage 3 (Millipore). ES-
neo and ES-hygro cells were derived from E14Tg2a and transduced with the
lentiviral pHRcPPT-PGK-neomycin and pHRcPPT-PGK-hygromycin vectors
(Zito et al., 2005). ES GSK-3 DKO cells were a gift from Dr. Doble, and they
were cultured as previously described (Doble et al., 2007). ESCs were cultured
on gelatin in knockout Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 20% fetal bovine serum (Hyclone), 13 nonessential amino acids,
13GlutaMax, 13 2-mercaptoethanol, and 1000 U/ml LIF ESGRO (Chemicon).
Cell Hybrids
ES3 NS and ES3MEF PEG fusions: 1.23 106 NS cells or MEFs were plated
into T25 flasks. After 2 hr, 1.2 3 106 ESCs were plated onto them, allowing
them to attach to the NS cells or MEFs. After a further 2 hr, 1 ml 50% (w/v)
PEG 1450 (Sigma; prewarmed to 37C) was added for 2min, and then the cells
were washed three times with serum-free DMEM. Finally, they were cultivated
with ESC complete medium without and with 1 mM BIO (Calbiochem),
100 ng/ml Wnt3a (R&D Systems), or 50–100 ng/ml DKK1 (R&D Systems). After
12 hr, the cells were trypsinized and plated into gelatin + laminin-treated p100
dishes. For the ES3 NS selection, puromycin was added after 72 hr, while for
the ES 3 MEF selection, hygromycin + neomycin was added after 24 hr.
ES 3 thymocyte fusions: the cells were fused in suspensions as previously
described (Silva et al., 2006). After fusion, they were packed by centrifugation
and the supernatant was discarded. The pelleted cells were resuspended in
complete ESC medium and plated. The selection was carried out after 24 hr,
using hygromycin plus neomycin.
Pretreated-ES 3 NS PEG Fusions
1 3 106 ESCs were plated in p100 plates and treated for 96, 72, 48, 24, and
12 hr with 100 ng/ml Wnt3a or 1 mM BIO. On the last day, the cells were
trypsinized, counted, and plated on NS cells for fusions or harvested for
RNA and protein analyses. PEG fusions and drug selection were performed
as previously described.
In Vitro Differentiation of Hybrid Cells
The differentiation medium for the production of embryoid bodies consisted of
ESC maintenance medium with no LIF supplementation. The cells were
harvested by trypsinization, counted, and propagated in hanging drops
(400 single ESCs/30 ml initial drop) for 2 days before being transferred to
10 cm2 bacterial dishes. At day 5, the embryoid bodies were transferred
onto gelatinized p100 dishes.
Teratoma Production
Cells were trypsinized into single-cell suspensions and resuspended in
phosphate-buffered saline to a concentration of 1.53 107 cells/ml. These cells
were injected subcutaneously into the hind limbs of Fox Chase SCID mice
using a 25 gauge needle (200 ml). Teratomas were collected after 4 weeks
and were fixed, embedded, sectioned, and stained.
SUPPLEMENTAL DATA
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